Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Joe-Anthony Rotella, Shaun L. Greene, Zeff Koutsogiannis, Andis Graudins, Yit Hung Leang, Kelvin Kuan, Helen Baxter, Elyssia Bourke & Anselm Wong. (2020) Treatment for beta-blocker poisoning: a systematic review. Clinical Toxicology 58:10, pages 943-983.
Read now
Read now
Benoit Bailey. (2003) Glucagon in β‐Blocker and Calcium Channel Blocker Overdoses: A Systematic Review. Journal of Toxicology: Clinical Toxicology 41:5, pages 595-602.
Read now
Read now
Jeffrey N. Love, Jeffrey Love, John M. Howell, Joseph T. Newsome, David F. Skibbie, Linda W. Dickerson & Kimberly J. Henderson. (2000) The Effect of Sodium Bicarbonate on Propranolol-Induced Cardiovascular Toxicity in a Canine Model. Journal of Toxicology: Clinical Toxicology 38:4, pages 421-428.
Read now
Read now
Shigehito Sato, Mariko H. Tsuji, Naomitsu Okubo, Chikako Nishimoto & Hiroshi Naito. (1995) Combined Use of Glucagon and Milrinone May Not Be Preferable for Severe Propranolol Poisoning in the Canine Model. Journal of Toxicology: Clinical Toxicology 33:4, pages 337-342.
Read now
Read now
Shigehito Sato, Mariko H. Tsuji, Naomitsu Okubo & Hiroshi Naito. (1994) Milrinone Versus Glucagon: Comparative Hemodynamic Effects in Canine Propranolol Poisoning. Journal of Toxicology: Clinical Toxicology 32:3, pages 277-289.
Read now
Read now
Pierre Taboulet, Alain Cariou, Alain Berdeaux & Chantal Bismuth. (1993) Pathophysiology and Management of Self-Poisoning with Beta-Blockers. Journal of Toxicology: Clinical Toxicology 31:4, pages 531-551.
Read now
Read now
Articles from other publishers (39)
Nagendra Kumar Singh, Banshi Saboo, Sanjeev Phatak, Samuel Seidu, Viral Shah, Wasim Hanif & Asher Fawwad. (2023) Glucagon and cardiovascular disease. Journal of Diabetology 14:Supplement 1, pages S11-S15.
Crossref
Crossref
Jon B. Cole & Ann M. Arens. (2022) Cardiotoxic Medication Poisoning. Emergency Medicine Clinics of North America 40:2, pages 395-416.
Crossref
Crossref
Ki Young Huh, Jun Gi Hwang, Wonjung Shin, Seungjae BAEK, JaeDuk Choi, Nora Lee, Young Min Cho & Howard Lee. (2021)
A double‐blind, placebo‐controlled, single‐ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of
HM15136
, a novel long‐acting glucagon analogue, in healthy subjects
. Diabetes, Obesity and Metabolism 24:3, pages 411-420.
Crossref
Crossref
Shameen Salam, Brandon Nornhold & Jihad Mallat. (2021) Massive metoprolol overdose requiring ECMO: brief review of the evidence behind recommended treatments. BMJ Case Reports 14:5, pages e232130.
Crossref
Crossref
Aaron Skolnik & Jessica Monas. (2020) The Crashing Toxicology Patient. Emergency Medicine Clinics of North America 38:4, pages 841-856.
Crossref
Crossref
Jon B Cole, Justin N Corcoran, Kristin M Engebretsen & Samuel J Stellpflug. (2020) Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning. Journal of Medical Toxicology 16:2, pages 212-221.
Crossref
Crossref
Kasper Meidahl Petersen, Søren Bøgevig, Jens Juul Holst, Filip Krag Knop & Mikkel Bring Christensen. (2018) Hemodynamic Effects of Glucagon: A Literature Review. The Journal of Clinical Endocrinology & Metabolism 103:5, pages 1804-1812.
Crossref
Crossref
Michael Levine & Jeffrey Brent. 2018. Critical Care Toxicology. Critical Care Toxicology
1
16
.
Michael Levine & Jeffrey Brent. 2017. Critical Care Toxicology. Critical Care Toxicology
771
786
.
Hallam Gugelmann & Neal Benowitz. 2017. Critical Care Toxicology. Critical Care Toxicology
475
507
.
Hallam Gugelmann & Neal Benowitz. 2016. Critical Care Toxicology. Critical Care Toxicology
1
34
.
Ramachandran Meenakshisundaram, Douglas Ewan Cannie, P. Ravi Shankar, Heidar Z. Zadeh, Omi Bajracharya & Ponniah Thirumalaikolundusubramanian. 2015. Heart and Toxins. Heart and Toxins
225
274
.
Michael Levine & Jeffrey Brent. 2016. Critical Care Toxicology. Critical Care Toxicology
1
16
.
Laurie J. Morrison, Charles D. Deakin, Peter T. Morley, Clifton W. Callaway, Richard E. Kerber, Steven L. Kronick, Eric J. Lavonas, Mark S. Link, Robert W. Neumar, Charles W. Otto, Michael Parr, Michael Shuster, Kjetil Sunde, Mary Ann Peberdy, Wanchun Tang, Terry L. Vanden Hoek, Bernd W. Böttiger, Saul Drajer, Swee Han Lim, Jerry P. Nolan, Christophe Adrie, Mohammed Alhelail, Pavan Battu, Wilhelm Behringer, Lauren Berkow, Richard A. Bernstein, Sadiq S. Bhayani, Blair Bigham, Jeff Boyd, Barry Brenner, Eric Bruder, Hermann Brugger, Ian L. Cash, Maaret Castrén, Michael Cocchi, Gregory Comadira, Kate Crewdson, Michael S. Czekajlo, Suzanne R. Davies, Harinder Dhindsa, Deborah Diercks, C. Jessica Dine, Csaba Dioszeghy, Michael Donnino, Joel Dunning, Nabil El Sanadi, Heather Farley, Peter Fenici, V. Ramana Feeser, Jane A.H. Foster, Hans Friberg, Michael Fries, F. Javier Garcia-Vega, Romergryko G. Geocadin, Marios Georgiou, Jaspinder Ghuman, Melissa Givens, Colin Graham, David M. Greer, Henry R. Halperin, Amanda Hanson, Michael Holzer, Elizabeth A. Hunt, Masami Ishikawa, Marios Ioannides, Farida M. Jeejeebhoy, Paul A. Jennings, Hitoshi Kano, Karl B. Kern, Fulvio Kette, Peter J. Kudenchuk, Douglas Kupas, Giuseppe La Torre, Todd M. Larabee, Marion Leary, John Litell, Charles M. Little, David Lobel, Timothy J. Mader, James J. McCarthy, Michael C. McCrory, James J. Menegazzi, William J. Meurer, Paul M. Middleton, Allan R. Mottram, Eliano Pio Navarese, Thomas Nguyen, Marcus Ong, Andrew Padkin, Edison Ferreira de Paiva, Rod S. Passman, Tommaso Pellis, John J. Picard, Rachel Prout, Morten Pytte, Renee D. Reid, Jon Rittenberger, Will Ross, Sten Rubertsson, Malin Rundgren, Sebastian G. Russo, Tetsuya Sakamoto, Claudio Sandroni, Tommaso Sanna, Tomoyuki Sato, Sudhakar Sattur, Andrea Scapigliati, Richard Schilling, Ian Seppelt, Fred A. Severyn, Greene Shepherd, Richard D. Shih, Markus Skrifvars, Jasmeet Soar, Keiichi Tada, Sara Tararan, Michel Torbey, Jonathan Weinstock, Volker Wenzel, Christoph H. Wiese, Daniel Wu, Carolyn M. Zelop, David Zideman & Janice L. Zimmerman. (2010) Part 8: Advanced Life Support. Circulation 122:16_suppl_2.
Crossref
Crossref
Charles D. Deakin, Laurie J. Morrison, Peter T. Morley, Clifton W. Callaway, Richard E. Kerber, Steven L. Kronick, Eric J. Lavonas, Mark S. Link, Robert W. Neumar, Charles W. Otto, Michael Parr, Michael Shuster, Kjetil Sunde, Mary Ann Peberdy, Wanchun Tang, Terry L. Vanden Hoek, Bernd W. Böttiger, Saul Drajer, Swee Han Lim & Jerry P. Nolan. (2010) Part 8: Advanced life support. Resuscitation 81:1, pages e93-e174.
Crossref
Crossref
David J. Roberts. 2010. Rosen's Emergency Medicine – Concepts and Clinical Practice. Rosen's Emergency Medicine – Concepts and Clinical Practice
1978
1988
.
Samir Fahed, Daniel F Grum & Thomas J Papadimos. (2008) Labetalol infusion for refractory hypertension causing severe hypotension and bradycardia: an issue of patient safety. Patient Safety in Surgery 2:1.
Crossref
Crossref
Angela C. Anderson. (2008) Management of Beta-Adrenergic Blocker Poisoning. Clinical Pediatric Emergency Medicine 9:1, pages 4-16.
Crossref
Crossref
Janice L. Zimmerman & Maria Rudis. 2008. Critical Care Medicine. Critical Care Medicine
1453
1474
.
William KernsIIII. (2007) Management of β-Adrenergic Blocker and Calcium Channel Antagonist Toxicity. Emergency Medicine Clinics of North America 25:2, pages 309-331.
Crossref
Crossref
Greene Shepherd. (2006) Treatment of poisoning caused by β-adrenergic and calcium-channel blockers. American Journal of Health-System Pharmacy 63:19, pages 1828-1835.
Crossref
Crossref
Jeffrey N Love & Neal Sikka. (2004) Are 1–2 tablets dangerous? Beta-blocker exposure in toddlers. The Journal of Emergency Medicine 26:3, pages 309-314.
Crossref
Crossref
Christopher R DeWitt & Javier C Waksman. (2004) Pharmacology, Pathophysiology and Management of Calcium Channel Blocker and ??-Blocker Toxicity. Toxicological Reviews 23:4, pages 223-238.
Crossref
Crossref
Jeffrey N. Love, Brett Enlow, John M. Howell, Wendy Klein-Schwartz & Toby L. Litovitz. (2002) Electrocardiographic changes associated with β-blocker toxicity. Annals of Emergency Medicine 40:6, pages 603-610.
Crossref
Crossref
Dakshina R. Murthy, C. Michael White, Deborah Katten, Alan W. Ahlberg, Ahmad Salloum & Gary V. Heller. (2012) Effect of Intravenous Metoprolol or Intravenous Metoprolol plus Glucagon on Dobutamine‐Induced Myocardial Ischemia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20:11, pages 1303-1309.
Crossref
Crossref
James S. Wohl & Terrence P. Clark. (2007) Pressor Therapy in Critically III Patients. Journal of Veterinary Emergency and Critical Care 10:1, pages 21-34.
Crossref
Crossref
C. Michael White. (2013) A Review of Potential Cardiovascular Uses of Intravenous Glucagon Administration. The Journal of Clinical Pharmacology 39:5, pages 442-447.
Crossref
Crossref
Jeffrey N. Love, Deepak K. Sachdeva, Edward S. Bessman, Liesl A. Curtis & John M. Howell. (1998) A Potential Role for Glucagon in the Treatment of Drug-Induced Symptomatic Bradycardia. Chest 114:1, pages 323-326.
Crossref
Crossref
Jeffrey N LoveMDMD. (1998) The Effect of Propranolol Intoxication on QTc Interval in a Canine Model. The Journal of Emergency Medicine 16:1, pages 1-4.
Crossref
Crossref
William KernsIIII, Mary Ransom, Christian Tomaszewski & Richard Raymond. (2008) The Effect of Hypertonic Sodium and Dantrolene on Propranolol Cardiotoxicity. Academic Emergency Medicine 4:6, pages 545-551.
Crossref
Crossref
William KernsIIII, David Schroeder?Cliff Williams?Christian Tomaszewski & Richard Raymond. (1997) Insulin Improves Survival in a Canine Model of Acute ?-Blocker Toxicity. Annals of Emergency Medicine 29:6, pages 748-757.
Crossref
Crossref
Shaheed I. Koury, C. Keith Stone & Stephen H. Thomas. (2008) Amrinone as an Antidote in Experimental Veraparnil Overdose. Academic Emergency Medicine 3:8, pages 762-767.
Crossref
Crossref
Arthur E. Toet, Anton Van De Kuil, Wim Vleeming, Johan Wemer, Wihelmina Bode, Jan Meulenbelt & Dick J. De Wildt. (1996) Toxic doses ofrac-, (?)-(S)- and (+)-(R)-propranolol in rats and rabbits. Chirality 8:6, pages 411-417.
Crossref
Crossref
Luiz G. R. DeLima, Evan D. Kharasch & Stephen Butler. (1995) Successful Pharmacologic Treatment of Massive Atenolol Overdose. Anesthesiology 83:1, pages 204-207.
Crossref
Crossref
William KernsIIII, Jeffrey Kline & Marsha D. Ford. (1994) β-Blocker and Calcium Channel Blocker Toxicity. Emergency Medicine Clinics of North America 12:2, pages 365-390.
Crossref
Crossref
Marin H. Kollef. (1994) Labetalol Overdose Successfully Treated With Amrinone and Alpha-Adrenergic Receptor Agonists. Chest 105:2, pages 626-627.
Crossref
Crossref
Leslie R Wolf, Michael P Spadafora & Edward J Otten. (1993) Use of amrinone and glucagon in a case of calcium channel blocker overdose. Annals of Emergency Medicine 22:7, pages 1225-1228.
Crossref
Crossref
Jeffrey N. Love, James A. Leasure & Diane J. Mundt. (1993) A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine model. The American Journal of Emergency Medicine 11:4, pages 360-363.
Crossref
Crossref
John A. Henry. 1993. Glucagon in Acute Medicine. Glucagon in Acute Medicine
67
81
.